Page 1 | Search Results | Blood | American Society of Hematology

1-9 of 9

Sort by

Sort Order Select

Journal Articles

BEACOPP chemotherapy is a highly effective regimen in children and adolescents with high-risk Hodgkin lymphoma: a report from the Children's Oncology Group

Kara M. Kelly, Richard Sposto, Raymond Hutchinson, Vickie Massey, Kathleen McCarten, Sherrie Perkins, Mark Lones, Doojduen Villaluna, Michael Weiner

Blood (2011) 117 (9): 2596–2603.

https://doi.org/10.1182/blood-2010-05-285379

Published: 2011

Journal Articles

Prevalence and Predictors of Self-Reported Neuropsychological Impairment in Patients Undergoing Hematopoietic Cell Transplantation (HCT) - Impact On Return to Work After HCT.

Alysia Bosworth, Lennie Wong, Sunita Patel, Doojduen Villaluna, Mitzi Gonzales, Marcia Grant, Stephen J. Forman, Smita Bhatia

Blood (2009) 114 (22): 808.

https://doi.org/10.1182/blood.V114.22.808.808

Published: 2009

Journal Articles

Neurocognitive Function and Its Impact On Return to Work in Patients Treated with Hematopoietic Cell Transplantation (HCT).

F. Lennie Wong, PhD, Alysia Bosworth, Rose Danao, Doojduen Villaluna, MS, Sunita Patel, PhD, Marcia Grant, RN, DNSc, FAAN, Stephen J Forman, MD, Smita Bhatia, MD, MPH

Blood (2009) 114 (22): 521.

https://doi.org/10.1182/blood.V114.22.521.521

Published: 2009

Journal Articles

A risk-adapted, response-based approach using ABVE-PC for children and adolescents with intermediate- and high-risk Hodgkin lymphoma: the results of P9425

Cindy L. Schwartz, Louis S. Constine, Doojduen Villaluna, Wendy B. London, Robert E. Hutchison, Richard Sposto, Steven E. Lipshultz, Charles S. Turner, Pedro A. deAlarcon, Allen Chauvenet

Blood (2009) 114 (10): 2051–2059.

https://doi.org/10.1182/blood-2008-10-184143

Published: 2009

Includes: Supplemental data

Journal Articles

Prevalence and Predictors of Non-Adherence to 6-Mercaptopurine (6MP) in Children with Acute Lymphoblastic Leukemia (ALL) - a Children’s Oncology Group Study.

Smita Bhatia, MD, MPH, Doojduen Villaluna, MS, Wendy Landier, RN, MSN, Alexandra Schaible, BS, Lindsey Hageman, MPH, Cara Hanby, BA, Wendy Leisenring, Sc.D., Stephen P. Hunger, MD, Leslie L. Robison, PhD, MPH, Mary V. Relling, PharmD, F. Lennie Wong, PhD

Blood (2008) 112 (11): 897.

https://doi.org/10.1182/blood.V112.11.897.897

Published: 2008

Journal Articles

Pharmacogenetic Predictors of Toxicity in Dose-Intensive Therapy for Pediatric Advanced-Stage Hodgkin’s Lymphoma.

John P. Perentesis, MD, Doojduen Villaluna, MS, Stella M. Davies, MBBS, PhD, Xiaowen Zhai, MD, PhD, Gretchen A. Radloff, MS, Michael A. Weiner, MD, Richard Sposto, PhD, Kara M. Kelly, MD

Blood (2006) 108 (11): 100.

https://doi.org/10.1182/blood.V108.11.100.100

Published: 2006

Journal Articles

Analysis of prognostic factors of acute lymphoblastic leukemia in infants: report on CCG 1953 from the Children's Oncology Group

Joanne M. Hilden, Patricia A. Dinndorf, Sharon O. Meerbaum, Harland Sather, Doojduen Villaluna, Nyla A. Heerema, Ron McGlennen, Franklin O. Smith, William G. Woods, Wanda L. Salzer, Helen S. Johnstone, Zoann Dreyer, Gregory H. Reaman

Blood (2006) 108 (2): 441–451.

https://doi.org/10.1182/blood-2005-07-3011

Published: 2006

Journal Articles

CCG 1953: Acute Lymphoblastic Leukemia in Infants: Analysis of Prognostic Factors: A Report from the Children’s Oncology Group.

Joanne M. Hilden, MD, Patricia A. Dinndorf, MD, Sharon O. Meerbaum, Harland Sather, PhD, Doojduen Villaluna, PhD, Nyla A. Heerema, PhD, Ron McGlennen, MD, Franklin O. Smith, MD, William G. Woods, MD, Zoann Dryer, MD, Gregory H. Reaman, MD

Blood (2005) 106 (11): 7.

https://doi.org/10.1182/blood.V106.11.7.7

Published: 2005

Journal Articles

Cyclosporine, Interferon-γ , and Interleukin-2 Immunotherapy Is Tolerable and Induces Autoreactivity in Patients with Recurrent/Refractory Hodgkin Disease Undergoing Autologous Stem Cell Transplantation with BEAM: A COG Study.

Allen Chen, MD, PhD, Allan Hess, PhD, Sharon Gardner, MD, Tanya Trippett, MD, Pedro de Alarcon, MD, Robert Guillerman, MD, Shirley Hogan, PharmD, Joy Mitchell, Alan Gamis, MD, Vicki Massey, MD, Louis S. Constine, MD, Doojduen Villaluna, MS, Richard Sposto, MD, Cindy Schwartz, MD

Blood (2005) 106 (11): 2087.

https://doi.org/10.1182/blood.V106.11.2087.2087

Published: 2005

NARROW

BEACOPP chemotherapy is a highly effective regimen in children and adolescents with high-risk Hodgkin lymphoma: a report from the Children's Oncology Group

Prevalence and Predictors of Self-Reported Neuropsychological Impairment in Patients Undergoing Hematopoietic Cell Transplantation (HCT) - Impact On Return to Work After HCT.

Neurocognitive Function and Its Impact On Return to Work in Patients Treated with Hematopoietic Cell Transplantation (HCT).

A risk-adapted, response-based approach using ABVE-PC for children and adolescents with intermediate- and high-risk Hodgkin lymphoma: the results of P9425

Prevalence and Predictors of Non-Adherence to 6-Mercaptopurine (6MP) in Children with Acute Lymphoblastic Leukemia (ALL) - a Children’s Oncology Group Study.

Pharmacogenetic Predictors of Toxicity in Dose-Intensive Therapy for Pediatric Advanced-Stage Hodgkin’s Lymphoma.

Analysis of prognostic factors of acute lymphoblastic leukemia in infants: report on CCG 1953 from the Children's Oncology Group

CCG 1953: Acute Lymphoblastic Leukemia in Infants: Analysis of Prognostic Factors: A Report from the Children’s Oncology Group.

Cyclosporine, Interferon-γ , and Interleukin-2 Immunotherapy Is Tolerable and Induces Autoreactivity in Patients with Recurrent/Refractory Hodgkin Disease Undergoing Autologous Stem Cell Transplantation with BEAM: A COG Study.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only